Related Experiment Video
Updated: Apr 15, 2026

Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
Published on: July 6, 2022
Quantitative profiling of brain lipid raft proteome in a mouse model of fragile X syndrome
Magdalena Kalinowska1, Catherine Castillo1, Anna Francesconi1
1Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America.
Abstract:
Fragile X Syndrome, a leading cause of inherited intellectual disability and autism, arises from transcriptional silencing of the FMR1 gene encoding an RNA-binding protein, Fragile X Mental Retardation Protein (FMRP). FMRP can regulate the expression of approximately 4% of brain transcripts through its role in regulation of mRNA transport, stability and translation, thus providing a molecular rationale for its potential pleiotropic effects on neuronal and brain circuitry function. Several intracellular signaling pathways are dysregulated in the absence of FMRP suggesting that cellular deficits may be broad and could result in homeostatic changes. Lipid rafts are specialized regions of the plasma membrane, enriched in cholesterol and glycosphingolipids, involved in regulation of intracellular signaling. Among transcripts targeted by FMRP, a subset encodes proteins involved in lipid biosynthesis and homeostasis, dysregulation of which could affect the integrity and function of lipid rafts. Using a quantitative mass spectrometry-based approach we analyzed the lipid raft proteome of Fmr1 knockout mice, an animal model of Fragile X syndrome, and identified candidate proteins that are differentially represented in Fmr1 knockout mice lipid rafts. Furthermore, network analysis of these candidate proteins reveals connectivity between them and predicts functional connectivity with genes encoding components of myelin sheath, axonal processes and growth cones. Our findings provide insight to aid identification of molecular and cellular dysfunctions arising from Fmr1 silencing and for uncovering shared pathologies between Fragile X syndrome and other autism spectrum disorders.
Insights
Fragile X Syndrome is linked to FMR1 gene silencing. Researchers found altered proteins in lipid rafts of knockout mice, suggesting new therapeutic targets for intellectual disability and autism.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Fragile X Syndrome (FXS) is a primary genetic cause of intellectual disability and autism.
- It results from FMR1 gene silencing, impacting Fragile X Mental Retardation Protein (FMRP) levels.
- FMRP regulates numerous brain transcripts, influencing neuronal function and potentially causing broad cellular deficits.
Purpose of the Study:
- To investigate the role of FMRP in regulating lipid raft proteome.
- To identify molecular and cellular dysfunctions in FXS using an animal model.
- To explore potential shared pathologies between FXS and other autism spectrum disorders.
Main Methods:
- Quantitative mass spectrometry was used to analyze the lipid raft proteome.
- Fmr1 knockout mice, an FXS model, were studied.
- Network analysis was performed on identified candidate proteins.
Main Results:
- Proteins differentially represented in the lipid rafts of Fmr1 knockout mice were identified.
- Network analysis revealed functional connectivity between these proteins and genes related to myelin, axons, and growth cones.
- Dysregulation of lipid biosynthesis and homeostasis proteins was suggested.
Conclusions:
- FMRP deficiency impacts the lipid raft proteome, affecting neuronal structure and function.
- These findings offer insights into molecular deficits in FXS.
- The study highlights potential shared mechanisms between FXS and other autism spectrum disorders.
More Related Videos
11:01Quantitative Autoradiographic Method for Determination of Regional Rates of Cerebral Protein Synthesis In Vivo
Published on: June 28, 2019
10:59Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein
Published on: June 6, 2025